Khong PL, Kwong DL, Chan GC, Sham JS, Chan FL, Ooi GC (2003) Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study. AJNR Am J Neuroradiol 24:734–740
PubMed PubMed Central Google Scholar
Nagel BJ, Palmer SL, Reddick WE, Glass JO, Helton KJ, Wu S, Xiong X, Kun LE, Gajjar A, Mulhern RK (2004) Abnormal hippocampal development in children with medulloblastoma treated with risk-adapted irradiation. AJNR Am J Neuroradiol 25:1575–1582
PubMed PubMed Central Google Scholar
Kovanlikaya A, Panigrahy A, Krieger MD, Gonzalez-Gomez I, Ghugre N, McComb JG, Gilles FH, Nelson MD, Blüml S (2005) Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. Radiology 236:1020–1025. https://doi.org/10.1148/radiol.2363040856
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109. https://doi.org/10.1007/s00401-007-0243-4
Article PubMed PubMed Central Google Scholar
Douglas-Akinwande AC, Payner TD, Hattab EM (2009) Medulloblastoma mimicking Lhermitte-Duclos disease on MRI and CT. Clin Neurol Neurosurg 111:536–539. https://doi.org/10.1016/j.clineuro.2009.01.008
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. https://doi.org/10.1093/neuonc/noab106
Article PubMed PubMed Central Google Scholar
Li Z, Wei Y, Shao Y, Tang L, Gong J (2021) Multi-omics analysis of intertumoral heterogeneity within medulloblastoma uncharted-pathway subtypes. Brain Tumor Pathol 38:234–242. https://doi.org/10.1007/s10014-021-00400-7
Article CAS PubMed Google Scholar
Khanna V, Achey RL, Ostrom QT, Block-Beach H, Kruchko C, Barnholtz-Sloan JS, de Blank PM (2017) Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013. J Neurooncol 135:433–441. https://doi.org/10.1007/s11060-017-2594-6
Gudrunardottir T, Lannering B, Remke M, Taylor MD, Wells EM, Keating RF, Packer RJ (2014) Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review. Childs Nerv Syst 30:979–990. https://doi.org/10.1007/s00381-014-2388-5
Zhu C, Preissl S, Ren B (2020) Single-cell multimodal omics: the power of many. Nat Methods 17:11–14. https://doi.org/10.1038/s41592-019-0691-5
Article CAS PubMed Google Scholar
Zhang ZY, Xu J, Ren Y, Li KK, Ng HK, Mao Y, Zhong P, Yao Y, Zhou LF (2014) Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy. PLoS ONE 9:e99490. https://doi.org/10.1371/journal.pone.0099490
Article CAS PubMed PubMed Central Google Scholar
Quinlan A, Rizzolo D (2017) Understanding medulloblastoma. JAAPA 30:30–36. https://doi.org/10.1097/01.Jaa.0000524717.71084.50
Gieryng A, Pszczolkowska D, Walentynowicz KA, Rajan WD, Kaminska B (2017) Immune microenvironment of gliomas. Lab Invest 97:498–518. https://doi.org/10.1038/labinvest.2017.19
Article CAS PubMed Google Scholar
Shen DD, Pang JR, Bi YP, Zhao LF, Li YR, Zhao LJ, Gao Y, Wang B, Wang N, Wei L et al (2022) LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer. Mol Cancer 21:75. https://doi.org/10.1186/s12943-022-01557-1
Article CAS PubMed PubMed Central Google Scholar
Creaney J, Patch AM, Addala V, Sneddon SA, Nones K, Dick IM, Lee YCG, Newell F, Rouse EJ, Naeini MM et al (2022) Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma. Genome Med 14:58. https://doi.org/10.1186/s13073-022-01060-8
Article CAS PubMed PubMed Central Google Scholar
Aziz HM, Saida L, de Koning W, Stubbs AP, Li Y, Sideras K, Palacios E, Feliu J, Mendiola M, van Eijck CHJ et al (2022) Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors. Front Immunol 13:995715. https://doi.org/10.3389/fimmu.2022.995715
Article CAS PubMed Google Scholar
Sakamoto S, Kagawa S, Kuwada K, Ito A, Kajioka H, Kakiuchi Y, Watanabe M, Kagawa T, Yoshida R, Kikuchi S et al (2019) Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer. Oncoimmunology 8:e1671760. https://doi.org/10.1080/2162402X.2019.1671760
Article PubMed PubMed Central Google Scholar
Saraiva DP, Matias AT, Braga S, Jacinto A, Cabral MG (2020) Establishment of a 3D co-culture With MDA-MB-231 breast cancer cell line and patient-derived immune cells for application in the development of immunotherapies. Front Oncol 10:1543. https://doi.org/10.3389/fonc.2020.01543
Article PubMed PubMed Central Google Scholar
Delmonte OM, Fleisher TA (2019) Flow cytometry: surface markers and beyond. J Allergy Clin Immunol 143:528–537. https://doi.org/10.1016/j.jaci.2018.08.011
Article CAS PubMed Google Scholar
Cossarizza A, Chang HD, Radbruch A, Abrignani S, Addo R, Akdis M, Andra I, Andreata F, Annunziato F, Arranz E et al (2021) Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur J Immunol 51:2708–3145. https://doi.org/10.1002/eji.202170126
Article CAS PubMed Google Scholar
Kanegane H, Hoshino A, Okano T, Yasumi T, Wada T, Takada H, Okada S, Yamashita M, Yeh TW, Nishikomori R et al (2018) Flow cytometry-based diagnosis of primary immunodeficiency diseases. Allergol Int 67:43–54. https://doi.org/10.1016/j.alit.2017.06.003
Article CAS PubMed Google Scholar
Griesinger AM, Birks DK, Donson AM, Amani V, Hoffman LM, Waziri A, Wang M, Handler MH, Foreman NK (2013) Characterization of distinct immunophenotypes across pediatric brain tumor types. J Immunol 191:4880–4888. https://doi.org/10.4049/jimmunol.1301966
Article CAS PubMed Google Scholar
Oshige H, Yamahara T, Oishi T, Li Y, Zhen Y, Numa Y, Kawamoto K (2010) Flow cytometric analysis for the mechanism of the new antineoplastic agent temozolomide in glioma cells. Brain Tumor Pathol 27:7–15. https://doi.org/10.1007/s10014-009-0259-7
Article CAS PubMed Google Scholar
Tan WCC, Nerurkar SN, Cai HY, Ng HHM, Wu D, Wee YTF, Lim JCT, Yeong J, Lim TKH (2020) Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy. Cancer Commun (Lond) 40:135–153. https://doi.org/10.1002/cac2.12023
Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM (2015) Psoriasis in children and adolescents: diagnosis. Manag Comorbidities Paediatr Drugs 17:373–384. https://doi.org/10.1007/s40272-015-0137-1
Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y (2022) Single-cell RNA sequencing technologies and applications: a brief overview. Clin Transl Med 12:e694. https://doi.org/10.1002/ctm2.694
Article CAS PubMed PubMed Central Google Scholar
Papalexi E, Satija R (2018) Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol 18:35–45. https://doi.org/10.1038/nri.2017.76
Article CAS PubMed Google Scholar
Kolodziejczyk AA, Kim JK, Svensson V, Marioni JC, Teichmann SA (2015) The technology and biology of single-cell RNA sequencing. Mol Cell 58:610–620. https://doi.org/10.1016/j.molcel.2015.04.005
Article CAS PubMed Google Scholar
Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y, Qin S, Zhang L, Ouyang H, Du P et al (2021) A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184:792-809 e723. https://doi.org/10.1016/j.cell.2021.01.010
Article CAS PubMed Google Scholar
Qian J, Olbrecht S, Boeckx B, Vos H, Laoui D, Etlioglu E, Wauters E, Pomella V, Verbandt S, Busschaert P et al (2020) A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling. Cell Res 30:745–762. https://doi.org/10.1038/s41422-020-0355-0
留言 (0)